Use of the Chatbot “Vivibot” to Deliver Positive Psychology Skills and Promote Well-Being Among Young People After Cancer Treatment: Randomized Controlled Feasibility Trial

Abstract

Background Positive psychology interventions show promise for reducing psychosocial distress associated with health adversity and have the potential to be widely disseminated to young adults through technology. Objective This pilot randomized controlled trial examined the feasibility of delivering positive psychology skills via the Vivibot chatbot and its effects on key psychosocial well-being outcomes in young adults treated for cancer. Methods Young adults (age 18-29 years) were recruited within 5 years of completing active cancer treatment by using the Vivibot chatbot on Facebook messenger. Participants were randomized to either immediate access to Vivibot content (experimental group) or access to only daily emotion ratings and access to full chatbot content after 4 weeks (control). Created using a human-centered design process with young adults treated for cancer, Vivibot content includes 4 weeks of positive psychology skills, daily emotion ratings, video, and other material produced by survivors, and periodic feedback check-ins. All participants were assessed for psychosocial well-being via online surveys at baseline and weeks 2, 4, and 8. Analyses examined chatbot engagement and open-ended feedback on likability and perceived helpfulness and compared experimental and control groups with regard to anxiety and depression symptoms and positive and negative emotion changes between baseline and 4 weeks. To verify the main effects, follow-up analyses compared changes in the main outcomes between 4 and 8 weeks in the control group once participants had access to all chatbot content. Results Data from 45 young adults (36 women; mean age: 25 [SD 2.9]; experimental group: n=25; control group: n=20) were analyzed. Participants in the experimental group spent an average of 74 minutes across an average of 12 active sessions chatting with Vivibot and rated their experience as helpful (mean 2.0/3, SD 0.72) and would recommend it to a friend (mean 6.9/10; SD 2.6). Open-ended feedback noted its nonjudgmental nature as a particular benefit of the chatbot. After 4 weeks, participants in the experimental group reported an average reduction in anxiety of 2.58 standardized t-score units, while the control group reported an increase in anxiety of 0.7 units. A mixed-effects models revealed a trend-level (P=.09) interaction between group and time, with an effect size of 0.41. Those in the experimental group also experienced greater reductions in anxiety when they engaged in more sessions (z=–1.9, P=.06). There were no significant (or trend level) effects by group on changes in depression, positive emotion, or negative emotion. Conclusions The chatbot format provides a useful and acceptable way of delivering positive psychology skills to young adults who have undergone cancer treatment and supports anxiety reduction. Further analysis with a larger sample size is required to confirm this pattern.

A Physical Activity and Diet Program Delivered by Artificially Intelligent Virtual Health Coach: Proof-of-Concept Study

“…Using an identical search strategy, we updated this review in January 2020 and identified a further 11 studies. Similar to the previous review, most recent studies were aimed at mental health self-management (n=5) [ 10 - 12 ]. Single studies (n=3) used virtual assistants to provide patients with education and support for breast cancer [ 13 ], genetic counseling [ 14 ], and clinician training [ 15 ].…”

User Experience of a Chatbot Questionnaire Versus a Regular Computer Questionnaire: Prospective Comparative Study

“…In mental health, chatbots are already emerging as useful tools to provide psychological support to young adults undergoing cancer treatment [ 15 ]. However, literature investigating the effectiveness and acceptability of chatbot surveys in health care is limited.…”

Internet Cognitive Behavioral Therapy With or Without Face-to-Face Psychotherapy: A 12-Weeks Clinical Trial of Patients With Depression

“…Digital health is rapidly nascent, and a variety of future perspectives need considerations. First, the most important direction that needs to be tackled is the use of (i) chatbots using artificial intelligence and machine learning rather than decision trees, (ii) embodied conversational avatars, or even (iii) hackathons that have the potential to increase patients' therapy adherence, responsiveness, beneficial behavioral patterns, and social interactions to overcome depression and to pave the way to personalized medicine in mental health (49)(50)(51)(52)(53)(54)(55)(56)(57). Second, objective outcome measurements are important to emphasize the beneficial effect of online therapy trials using neuroimaging, e.g., diffusion tensor imaging and functional magnetic resonance imaging, which can help to elucidate microstructural changes in the white matter tracts of the interhemispheric and frontalsubcortical neural circuits that are impaired in depression (58), or to depict the striatal hypoactivation of the reward neuronal network within unipolar depression when anticipating and consuming rewards (59), or epigenetic and modifiable factors, e.g., the dense DNA methylation status of the glucocorticoid receptor gene (NR3C1), which is associated with early life stress and disposes to major depression disorder (60).…”